10-Q Filing

Oruka Therapeutics, Inc. CIK: 907654 Q2 2024

Filing Information

Form Type	10-Q
Accession Number	`0000950170-24-089246`
Period End Date	20240630
Filing Date	20240801
Fiscal Year	2024
Fiscal Period	Q2
XBRL Instance	abio-20240630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 102 Income Statement 88 Cash Flow Statement 84 Stockholders Equity 68

Balance Sheet 102 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$37.43M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$37.43M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.28M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.28M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$537.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$537.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$161.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$161.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$37.59M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$37.59M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$33.82M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$33.82M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Right-of-use asset - operating	`OperatingLeaseRightOfUseAsset`	$247.00K	USD	Point-in-time
Right-of-use asset - operating	`OperatingLeaseRightOfUseAsset`	$247.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Right-of-use asset - operating	`OperatingLeaseRightOfUseAsset`	$8.00K	USD	Point-in-time
Right-of-use asset - operating	`OperatingLeaseRightOfUseAsset`	$8.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	14.51M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	14.51M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	14.50M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	14.50M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$12.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$12.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$12.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$12.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	14.51M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	14.51M	shares	Point-in-time
Total assets	`Assets`	$33.84M	USD	Point-in-time
Total assets	`Assets`	$33.84M	USD	Point-in-time
Total assets	`Assets`	$37.86M	USD	Point-in-time
Total assets	`Assets`	$37.86M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	14.50M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	14.50M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$571.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$571.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$362.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$362.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$100.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$100.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$109.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$109.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherAccruedLiabilitiesCurrent`	$591.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherAccruedLiabilitiesCurrent`	$591.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherAccruedLiabilitiesCurrent`	$175.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherAccruedLiabilitiesCurrent`	$175.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.27M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.27M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$637.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$637.00K	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$204.00K	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$204.00K	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$1.27M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.27M	USD	Point-in-time
Total liabilities	`Liabilities`	$841.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$841.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at June 30, 2024 and December 31, 2023; 14,507,143 shares and 14,501,143 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$14.00K	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at June 30, 2024 and December 31, 2023; 14,507,143 shares and 14,501,143 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$14.00K	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at June 30, 2024 and December 31, 2023; 14,507,143 shares and 14,501,143 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$14.00K	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at June 30, 2024 and December 31, 2023; 14,507,143 shares and 14,501,143 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$14.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$225.99M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$225.99M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$225.75M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$225.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-188.74M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-188.74M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-193.43M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-193.43M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$37.02M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$37.02M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$41.67M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$41.67M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$39.24M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$39.24M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$35.12M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$35.12M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$37.97M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$37.97M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$32.57M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$32.57M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$40.53M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$40.53M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$33.84M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$33.84M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$37.86M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$37.86M	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`GeneralAndAdministrativeExpense`	$1.72M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.72M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.99M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.99M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.31M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.31M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.12M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.12M	USD	2 Qtrs
Research and development (related party - $0 in 2024; and $108 and $216 as of the three and six months ended June 30, 2023, respectively)	`ResearchAndDevelopmentExpense`	$130.00K	USD	1 Quarter
Research and development (related party - $0 in 2024; and $108 and $216 as of the three and six months ended June 30, 2023, respectively)	`ResearchAndDevelopmentExpense`	$130.00K	USD	1 Quarter
Research and development (related party - $0 in 2024; and $108 and $216 as of the three and six months ended June 30, 2023, respectively)	`ResearchAndDevelopmentExpense`	$254.00K	USD	1 Quarter
Research and development (related party - $0 in 2024; and $108 and $216 as of the three and six months ended June 30, 2023, respectively)	`ResearchAndDevelopmentExpense`	$254.00K	USD	1 Quarter
Research and development (related party - $0 in 2024; and $108 and $216 as of the three and six months ended June 30, 2023, respectively)	`ResearchAndDevelopmentExpense`	$295.00K	USD	2 Qtrs
Research and development (related party - $0 in 2024; and $108 and $216 as of the three and six months ended June 30, 2023, respectively)	`ResearchAndDevelopmentExpense`	$295.00K	USD	2 Qtrs
Research and development (related party - $0 in 2024; and $108 and $216 as of the three and six months ended June 30, 2023, respectively)	`ResearchAndDevelopmentExpense`	$644.00K	USD	2 Qtrs
Research and development (related party - $0 in 2024; and $108 and $216 as of the three and six months ended June 30, 2023, respectively)	`ResearchAndDevelopmentExpense`	$644.00K	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$3.12M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$3.12M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$5.60M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$5.60M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$3.77M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$3.77M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$1.97M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$1.97M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.77M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.77M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.97M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.97M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.60M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.60M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.12M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.12M	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$444.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$444.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$493.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$493.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$943.00K	USD	2 Qtrs
Interest and other income	`InterestAndOtherIncome`	$943.00K	USD	2 Qtrs
Interest and other income	`InterestAndOtherIncome`	$917.00K	USD	2 Qtrs
Interest and other income	`InterestAndOtherIncome`	$917.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.69M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.69M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.20	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.20	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.10	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.10	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.18	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.18	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.32	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.32	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.32	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.32	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.10	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.10	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.20	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.20	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.18	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.18	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	14.51M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	14.51M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	14.41M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	14.41M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	14.41M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	14.41M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	14.50M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	14.50M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	14.50M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	14.50M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	14.41M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	14.41M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	14.41M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	14.41M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	14.51M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	14.51M	shares	1 Quarter

Cash Flow Statement 84 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.69M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.69M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Depreciation	`DepreciationAndAmortization`	$8.00K	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$8.00K	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$6.00K	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$6.00K	USD	2 Qtrs
Amortization of right-of-use asset - operating	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$50.00K	USD	2 Qtrs
Amortization of right-of-use asset - operating	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$50.00K	USD	2 Qtrs
Amortization of right-of-use asset - operating	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$25.00K	USD	2 Qtrs
Amortization of right-of-use asset - operating	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$25.00K	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$226.00K	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$226.00K	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$391.00K	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$391.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$376.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$376.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$345.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$345.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-93.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-93.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$209.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$209.00K	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$17.00K	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$17.00K	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$9.00K	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$9.00K	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$426.00K	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$426.00K	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$509.00K	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$509.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.29M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.29M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.16M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.16M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Proceeds from issuance of common stock associated with stock options	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$14.00K	USD	2 Qtrs
Proceeds from issuance of common stock associated with stock options	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$14.00K	USD	2 Qtrs
Proceeds from issuance of common stock associated with stock options	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	-	USD	2 Qtrs
Proceeds from issuance of common stock associated with stock options	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$14.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$14.00K	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.29M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.29M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-4.15M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-4.15M	USD	2 Qtrs
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$33.28M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$33.28M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$40.16M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$40.16M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$37.43M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$37.43M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.45M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.45M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$33.28M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$33.28M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$40.16M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$40.16M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$37.43M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$37.43M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.45M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.45M	USD	Point-in-time
Leased assets and operating lease liabilities - amended lease term	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Leased assets and operating lease liabilities - amended lease term	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Leased assets and operating lease liabilities - amended lease term	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$214.00K	USD	2 Qtrs
Leased assets and operating lease liabilities - amended lease term	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$214.00K	USD	2 Qtrs

Stockholders Equity 68 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$37.02M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$37.02M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$41.67M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$41.67M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$39.24M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$39.24M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$35.12M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$35.12M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$37.97M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$37.97M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$32.57M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$32.57M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$40.53M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$40.53M	USD	Point-in-time
Beginning Balance, shares	`CommonStockSharesOutstanding`	14.51M	shares	Point-in-time
Beginning Balance, shares	`CommonStockSharesOutstanding`	14.51M	shares	Point-in-time
Beginning Balance, shares	`CommonStockSharesOutstanding`	14.50M	shares	Point-in-time
Beginning Balance, shares	`CommonStockSharesOutstanding`	14.50M	shares	Point-in-time
Issuance of common stock upon stock option exercise, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	6,000.00	shares	2 Qtrs
Issuance of common stock upon stock option exercise, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	6,000.00	shares	2 Qtrs
Issuance of common stock upon stock option exercise, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$14.00K	USD	1 Quarter
Issuance of common stock upon stock option exercise, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$14.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$187.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$187.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$154.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$154.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$112.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$112.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$141.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$141.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$204.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$204.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$114.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$114.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.69M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.69M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.68M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Ending Balance	`StockholdersEquity`	$37.02M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$37.02M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$41.67M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$41.67M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$39.24M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$39.24M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$35.12M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$35.12M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$37.97M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$37.97M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$32.57M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$32.57M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$40.53M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$40.53M	USD	Point-in-time
Ending Balance, shares	`CommonStockSharesOutstanding`	14.51M	shares	Point-in-time
Ending Balance, shares	`CommonStockSharesOutstanding`	14.51M	shares	Point-in-time
Ending Balance, shares	`CommonStockSharesOutstanding`	14.50M	shares	Point-in-time
Ending Balance, shares	`CommonStockSharesOutstanding`	14.50M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.